Fukushima Journalof Medical Science

Fukushima Society of Medical Science

Contact usPrivacy Policy

Abstract/References

Current issue
Archive

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:its history and development, and regional medical cooperation in Fukushima

Kazuhiko Nakazato, Koichi Sugimoto, Masayoshi Oikawa, Yasuchika Takeishi

Author information

  • Kazuhiko Nakazato

    Regional Medical Support Center, Fukushima Medical University
    Department of Cardiovascular Medicine, Fukushima Medical University

  • Koichi Sugimoto

    Department of Cardiovascular Medicine, Fukushima Medical University
    Futaba Emergency and General Medicine Support Center, Fukushima Medical University

  • Masayoshi Oikawa

    Department of Cardiovascular Medicine, Fukushima Medical University

  • Yasuchika Takeishi

    Department of Cardiovascular Medicine, Fukushima Medical University

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is designated as an intractable disease by the Ministry of Health, Labour and Welfare of Japan, and has an extremely poor prognosis if untreated. Surgical pulmonary endarterectomy is the curative treatment for cases in which the organized thrombi are located in the central part of the pulmonary artery, but there had been no effective treatment for cases in which the thrombi are located in the peripheral part of the pulmonary artery. Recently, balloon pulmonary angioplasty (BPA), a transcatheter procedure to dilate stenotic or occluded lesions in the peripheral pulmonary artery, has been rapidly developed. Although BPA was once a globally abandoned procedure due to hemorrhagic complications, Japanese experts have improved the technique, and its safety and efficacy have been enhanced. As a result, BPA is now being reevaluated worldwide. This review describes the history and development of BPA in the treatment of CTEPH, as well as the status of this treatment in Fukushima Prefecture.

The cintent of reseach paper

References

1. Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J, 53:1801915, 2019.


2. Fukuda K. Guidelines for Treatment of Pulmonary Hypertension. JCS 2017/JPCPHS 2017 (in Japanease). 2018. (https://www.j-circ.or.jp/cms/wp-content/uploads/2017/10/JCS2017_fukuda_h.pdf)


3. Number of recipients of designated intractable diseases in 2021 (Ministry of Health, Labour and Welfare Health Administration Report) (in Japanease). 2023.


4. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv, 5:748-755, 2012.


5. Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv, 5:756-762, 2012.


6. Sugimura K, Fukumoto Y, Satoh K, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J, 76:485-488, 2012.


7. Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med, 369:319-329, 2013.


8. Ogo T, Shimokawahara H, Kinoshita H, et al. Selexipag for the treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J, 60:2101694, 2022.


9. Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J, 57:2002828, 2021.


10. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension:the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 30:2493-2537, 2009.


11. Coquoz N, Weilenmann D, Stolz D, et al. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J, 51:1702505, 2018.


12. Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism:a contemporary view of the published literature. Eur Respir J, 49:1601792, 2017.


13. Frost A, Badesch D, Gibbs JSR, et al. Diagnosis of pulmonary hypertension. Eur Respir J, 53:1801904, 2019.


14. Korn D, Gore I, Blenke A, Collins DP. Pulmonary arterial bands and webs:an unrecognized manifestation of organized pulmonary emboli. Am J Pathol, 40:129-151, 1962.


15. Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest, 94:1249-1253, 1988.


16. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation, 103:10-13, 2001.


17. Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation, 130:508-518, 2014.


18. Ikeda N. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Cardiovasc Interv Ther, 35:130-141, 2020.


19. Hirakawa K, Yamamoto E, Takashio S, et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Cardiovasc Interv Ther, 37:60-65, 2022.


20. Nakazato K. BPA technique and its complications (in Japanease). Coronary Intervention, 12:19-27, 2016.


21. Kawakami T, Ogawa A, Miyaji K, et al. Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty. Circ Cardiovasc Interv, 9:e003318, 2016.


22. Inami T, Kataoka M, Shimura N, et al. Pressure-wire-guided percutaneous transluminal pulmonary angioplasty:a breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv, 7:1297-1306, 2014.


23. Ogawa A, Satoh T, Fukuda T, et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension:Results of a Multicenter Registry. Circ Cardiovasc Qual Outcomes, 10:e004029, 2017.


24. Ogo T, Fukuda T, Tsuji A, et al. Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography. Eur J Radiol, 89:270-276, 2017.


25. Ando K, Mochizuki A, Kurimoto N, et al. Coil embolization for pulmonary arteriovenous malformation as an organ-sparing therapy:outcome of long-term follow-up. Ann Thorac Cardiovasc Surg, 17:118-123, 2011.


26. Kaiser CA, Hugli RW, Haegeli LM, Pfisterer ME. Selective embolization of a pulmonary artery rupture caused by a Cournand catheter. Catheter Cardiovasc Interv, 61:317-319, 2004.


27. Ejiri K, Ogawa A, Matsubara H. Bail-out technique for pulmonary artery rupture with a covered stent in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv, 8:752-753, 2015.


28. Kataoka M, Inami T, Kawakami T, Fukuda K, Satoh T. Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension:A Japanese Perspective. JACC Cardiovasc Interv, 12:1382-1388, 2019.


29. Nakazato K, Sugimoto K, Kiko T, Kobayashi A, Takeishi Y. Angiographic and intravascular ultrasound images of pulmonary artery rupture during balloon pulmonary angioplasty. Eur Heart J Cardiovasc Imaging, 22:176, 2021.


30. Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart, 99:1415-1420, 2013.


31. Kurzyna M, Darocha S, Pietura R, et al. Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience. Kardiol Pol, 75:645-654, 2017.


32. Olsson KM, Wiedenroth CB, Kamp JC, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension:the initial German experience. Eur Respir J, 49:1602409, 2017.


33. Aoki T, Sugimura K, Tatebe S, et al. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications. Eur Heart J, 38:3152-3159, 2017.


34. Velazquez M, Albarran A, Hernandez I, et al. Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension. Observational Study in a Referral Unit. Rev Esp Cardiol (Engl Ed), 72:224-232, 2019.


35. Brenot P, Jais X, Taniguchi Y, et al. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J, 53:1802095, 2019.


36. Anand V, Frantz RP, DuBrock H, et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension:Initial Single-Center Experience. Mayo Clin Proc Innov Qual Outcomes, 3:311-318, 2019.


37. Kawakami T, Matsubara H, Shinke T, et al. Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA):an open-label, randomised controlled trial. Lancet Respir Med, 10:949-960, 2022.


38. Jais X, Brenot P, Bouvaist H, et al. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE):a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. Lancet Respir Med, 10:961-971, 2022.

Figures